Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Centanafadine: First Approval

Drugs. 2026 Oct 24. doi: 10.1007/s40265-026-02411-0. Online ahead of print.ABSTRACTCentanafadine (SIMTRIYO®) is a first-in-class, sustained-release norepinephrine, dopamine and serotonin reuptake inhibitor and central nervous system...

Male urinary incontinence

Rev Prat. 2026 Sep;76(7):740-743.ABSTRACTWhile not uncommon, urinary incontinence is less common in men than in women incidence increases, reaching up to 32% at age 80....
close chatgpt icon
ChatGPT

Enter your request.

→← CME/CPD